BR0108400A - Agente farmacológico e método de tratamento - Google Patents

Agente farmacológico e método de tratamento

Info

Publication number
BR0108400A
BR0108400A BR0108400-3A BR0108400A BR0108400A BR 0108400 A BR0108400 A BR 0108400A BR 0108400 A BR0108400 A BR 0108400A BR 0108400 A BR0108400 A BR 0108400A
Authority
BR
Brazil
Prior art keywords
metal
agent
antiinflammatory
preparations
treatment method
Prior art date
Application number
BR0108400-3A
Other languages
English (en)
Inventor
Jose A Fernandez-Pol
Avinash N Amin
Michael G Douglas
Original Assignee
Novactyl Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novactyl Inc filed Critical Novactyl Inc
Publication of BR0108400A publication Critical patent/BR0108400A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

"AGENTE FARMACOLóGICO E MéTODO DE TRATAMENTO". Um agente antiproliferativo, antiinflamatório, antiinfeccioso, de imunização de um agente de quelação de íon de metal tal como ácido picolínico, seus análogos ou derivados, e métodos de uso do mesmo. O agente quelantes de metais em complexos de proteína contendo metal e enzimas necessárias para crescimento, replicação ou resposta inflamatória. As preparações podem ser administradas sistemicamente ou topicamente. Os produtos podem ser usados para reduzir níveis sistêmicos de metais em estados de doença tal como doença de Wilson, toxidez de ferro ou chumbo. As preparações têm efeitos antineoplástico, antiviral, antiinflamatório, analgésico, antiangiogênico e antiproliferativo e são usados no tratamento de verrugas, psoríase, acne, cânceres, queimadura do sol, respostas inflamatórias, angiogênese refratária e outras doenças e na prevenção de doenças sexualmente transmissíveis tal como verrugas genitais, herpes e AIDS.
BR0108400-3A 2000-02-15 2001-02-15 Agente farmacológico e método de tratamento BR0108400A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18260800P 2000-02-15 2000-02-15
PCT/US2001/004897 WO2001060349A2 (en) 2000-02-15 2001-02-15 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof.

Publications (1)

Publication Number Publication Date
BR0108400A true BR0108400A (pt) 2003-03-11

Family

ID=22669217

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108400-3A BR0108400A (pt) 2000-02-15 2001-02-15 Agente farmacológico e método de tratamento

Country Status (10)

Country Link
US (1) US6403618B1 (pt)
EP (1) EP1257262A2 (pt)
JP (1) JP2003522786A (pt)
AU (1) AU781066B2 (pt)
BR (1) BR0108400A (pt)
DE (1) DE01909253T1 (pt)
ES (1) ES2215493T1 (pt)
MX (1) MXPA02007954A (pt)
TR (1) TR200301378T3 (pt)
WO (1) WO2001060349A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060074063A1 (en) * 1995-12-29 2006-04-06 Fernandez-Pol Jose A Pharmacological agent and method of treatment
US6579891B1 (en) * 1995-12-29 2003-06-17 Novactyl, Inc. Agent and method for prevention and treatment of cancer in animals
AU2002323368B2 (en) * 2001-08-23 2006-12-07 The Government Of The United States Of America As Represented By The Secretary, Department Of Health & Human Services Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives
WO2003055477A1 (en) * 2001-12-21 2003-07-10 7Tm Pharma A/S Method for the treatment of mc receptor related disorders with a chelate and/or a chelator
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
ES2330326T3 (es) 2002-05-24 2009-12-09 Angiotech International Ag Composiciones y metodos para recubrir implantes medicos.
WO2005051871A2 (en) * 2003-11-20 2005-06-09 Angiotech International Ag Implantable sensors and implantable pumps and anti-scarring agents
US20050147631A1 (en) * 2004-01-07 2005-07-07 Goldstein Mindy S. Cosmetic composition and method for retarding hair growth
US20050239723A1 (en) * 2004-04-27 2005-10-27 Amin Avinash N Compositions and methods useful for treatment of acne
US20070178062A1 (en) * 2005-10-07 2007-08-02 Nathan Ravi Treatment of presbyopia with picolinic acid and its analogs
EP1938107A2 (en) * 2005-10-20 2008-07-02 Viamet Pharmaceuticals, Inc. Screening for modulators of metalyation pathways for metalloproteins
US20120321573A1 (en) 2009-10-02 2012-12-20 The General Hospital Corporation Compositions and methods of prophylaxis for contact dermatitis
GB201317619D0 (en) 2013-10-04 2013-11-20 Uni I Oslo Compounds
CN109562100B (zh) * 2016-07-28 2021-07-20 江苏亚虹医药科技股份有限公司 多巴胺β-羟化酶(DBH)抑制剂和血清素受体(5-HT)拮抗剂用于治疗癌症的用途
GB201613946D0 (en) 2016-08-15 2016-09-28 Univ Oslo Compounds

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903285A (en) 1972-12-29 1975-09-02 Microbial Chem Res Found Method for treating parkinsonism
US4044140A (en) 1975-11-28 1977-08-23 Schering Corporation Trityl picolinic acid derivatives and their use as anti-acne agents
CH629488A5 (en) 1975-11-28 1982-04-30 Scherico Ltd Processes for preparing novel picolinic acid derivatives.
ZA767103B (en) 1975-11-28 1977-10-26 Scherico Ltd Picolinic acid derivatives and processes for their preparation
US4120762A (en) 1977-09-30 1978-10-17 Alden Research Foundation Electrochemical recording medium
US4293547A (en) 1980-08-25 1981-10-06 The Upjohn Company Method of treating malaria
US4443459A (en) 1981-05-26 1984-04-17 Banyu Pharmaceutical Co., Ltd. α-Tocopheryl ester of 5-substituted picolinic acid and hypotensive composition containing it
US4814351A (en) 1987-06-26 1989-03-21 Redken Laboratories, Inc. Scalp treatment
US5536743A (en) 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
US5057320A (en) 1988-08-01 1991-10-15 Nutrition 21 Means and method for increasing skin respiration
US5157046A (en) 1988-11-29 1992-10-20 Janssen Pharmaceutica N.V. Method of treating epithelial disorders
US5219847A (en) 1989-06-12 1993-06-15 Shiseido Company, Ltd. Antipruritic composition
FR2657259A1 (fr) 1990-01-25 1991-07-26 Adir Utilisation de la n-myristoyl-(s)-phenylalanine pour l'obtention de medicaments destines au traitement des maladies faisant intervenir la myristoylation.
US5484951A (en) 1990-10-19 1996-01-16 Octamer, Incorporated 5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents
US5403816A (en) 1990-10-25 1995-04-04 Kumiai Chemical Industry Co., Ltd. Picolinic acid derivative and herbicidal composition
US5391537A (en) 1990-10-25 1995-02-21 Kumiai Chemical Industry Co., Ltd. Picolinic acid derivative, and herbicidal composition
US5173486A (en) 1991-08-26 1992-12-22 Bristol-Myers Squibb Company Dibenz[b,f][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents
US5516941A (en) 1991-10-22 1996-05-14 Octamer, Inc. Specific inactivators of "retroviral" (asymmetric) zinc fingers
IL104323A0 (en) 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
US5284840A (en) 1992-06-12 1994-02-08 Merck & Co., Inc. Alkylidene macrolides having immunosuppressive activity
US5962463A (en) * 1992-10-09 1999-10-05 Massachusetts Institute Of Technology Methods of stimulating non-amyloidogenic processing of the amyloid precursor protein
EP0701446A4 (en) 1993-05-24 1997-04-23 Smithkline Beecham Corp HEMOREGULATORS PEPTIDES
US6001555A (en) 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
FR2736263B1 (fr) 1995-07-07 1997-09-26 C3D Sarl Composition dermocosmetique depigmentante et son utilisation
US5767135A (en) 1995-12-29 1998-06-16 Fernandez-Pol; Jose Alberto Antiviral agent
JP3337992B2 (ja) 1997-11-04 2002-10-28 ファイザー製薬株式会社 ５−置換ピコリン酸化合物及びその製造方法

Also Published As

Publication number Publication date
TR200301378T3 (tr) 2003-12-22
WO2001060349A2 (en) 2001-08-23
MXPA02007954A (es) 2004-09-10
DE01909253T1 (de) 2004-04-15
WO2001060349A3 (en) 2001-11-08
EP1257262A2 (en) 2002-11-20
US6403618B1 (en) 2002-06-11
AU3702801A (en) 2001-08-27
JP2003522786A (ja) 2003-07-29
WO2001060349B1 (en) 2001-12-27
ES2215493T1 (es) 2004-10-16
AU781066B2 (en) 2005-05-05

Similar Documents

Publication Publication Date Title
DE69635488D1 (de) Antivirale verbindung
BR0108400A (pt) Agente farmacológico e método de tratamento
WO2002020486A3 (en) Picolinic acid derivatives for the prevention and treatment of cancer in animals
UA41879C2 (uk) Засіб для лікування мотонейронових захворювань
EP0355152A4 (en) TOPICAL METRONIDAZOLE FORMULATIONS AND THE USE THEREOF AS MEDICINAL PRODUCTS.
EP0229654B1 (en) Treatment of non-acne inflammatory and infectious dermatoses
ATE42895T1 (de) Steroide als immunomodulierende mittel.
IT8320301A0 (it) Preparazioni liquide di diidropiridine, procedimento per la loro preparazione cosi' come il loro impiego nella cura delle malattie.
IL154693A (en) Use of testosterone gel to make a remedy for testosterone deficiency in women
MX9602973A (es) Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida.
HUP0001583A2 (hu) Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
MXPA01013460A (es) Formulaciones topicas que comprenden agentes de penetracion de la piel y uso de las mismas.
IT1260155B (it) Uso terapeutico della fosforil-l-serina-n-acil-sfingosina
DK178489A (da) Anthralin-sterol-komplekser, deres fremstilling og anvendelse
Bernus et al. Metal Working in the Agadez Region(Niger): an Ethno-Archaeological Approach.(Retroactive Coverage)
NO962619L (no) Psoriasisbehandling
ES8200346A1 (es) Un procedimiento para preparar 5-amino-(3,4'-bipiridin)-6(1h)-ona-1'-oxido o una de sus sales de adicion de acido
AR010457A1 (es) Composicion farmaceutica de acido picolinico o un derivado del mismo y metodos de tratamiento de enfermedades
AU621677B2 (en) Stable aqueous solutions of primycin, pharmaceutical and cosmetic compositions containing these solutions and process for preparing same
IT1257884B (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari a base di vincamina o di un suo sale farmaceuticamente accettabile.
JPS55133314A (en) Curing agent for trichophytosis
MY105595A (en) Stable aqueous solutions of primycin pharmaceutical and cosmetic compositions containing these solutions and process for preparing same
ECSP993206A (es) Metodo para mejorar la farmacocinetica del tipranavir
IT1254361B (it) Formulazione farmaceutica per uso topico, indicata nel trattamento di infezioni virali della pelle e delle mucose.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009